Calcium carbonate, sodium alginate, sodium bicarbonate
Sold as Gelacid, Gaviscon double action, Gaviscon tropical, Gaviscon peppermint, Gelusil plus, Clicks alginic antacid, Dis-chem alginic antacid, Gaviscon strawberry, Gaviscon lemon, Gaviscon double action liquid
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 3
- Registrations
- 12
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cipla Medpro (Pty) Ltd | Gelacid, Clicks alginic antacid, Dis-chem alginic antacid | suspension | 330046, 450040, 450041 | Not determined | None |
| Reckitt Benckinser Pharmaceuticals (Pty) LtdCertificate held by Reckitt benckiser pharmaceuticals | Gaviscon double action, Gaviscon tropical, Gaviscon peppermint, Gaviscon strawberry, Gaviscon lemon, Gaviscon double action liquid | tablets, granules, 10 ml, 250, 500 | 420263, 431104, 431105, A380444, A380445, A380446, A380447, A400480 | S0 | PIPIL |
| Inova Pharmaceuticals (Pty) Ltd | Gelusil plus | 500 mg / 267 mg / 160 mg | 431124 | Not determined | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Gelacid EACH 10,0 ml SUSPENSION CONTAINS CALCIUM CARBONATE 160,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 267,0 mg | Not listed | 33004633/11.10/0046 | Registered | Not determined | None |
| Gaviscon double action tablets EACH TABLET CONTAINS CALCIUM CARBONATE 187,50 mg SODIUM ALGINATE 250,0 mg SODIUM BICARBONATE 106,50 mg | Tablets | 42026342/11.10/0263 | Registered | Not determined | None |
| Gaviscon tropical granules EACH SACHET CONTAINS CALCIUM CARBONATE 160,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 267,0 mg | Granules | 43110443/13.1/1104 | Registered | Not determined | None |
| Gaviscon peppermint granules EACH SACHET CONTAINS CALCIUM CARBONATE 160,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 267,0 mg | Granules | 43110543/13.1/1105 | Registered | Not determined | None |
| Gelusil plus EACH 10,0 ml SUSPENSION CONTAINS CALCIUM CARBONATE 160,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 267,0 mg | 500 mg / 267 mg / 160 mgSuspension | 43112443/11.10/1124Approved 19 July 2021 | Registered | Not determined | PIPIL |
| Clicks alginic antacid suspension EACH 10,0 ml SUSPENSION CONTAINS CALCIUM CARBONATE 160,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 267,0 mg | Suspension | 45004045/11.10/0040 | Registered | Not determined | None |
| Dis-chem alginic antacid suspension EACH 10,0 ml SUSPENSION CONTAINS CALCIUM CARBONATE 160,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 267,0 mg | Suspension | 45004145/11.10/0041 | Registered | Not determined | None |
| Gaviscon 250 strawberry EACH TABLET CONTAINS CALCIUM CARBONATE 80,0 mg SODIUM ALGINATE 250,0 mg SODIUM BICARBONATE 133,5 mg | 250 | A380444A38/11.10/0444 | Registered | Not determined | None |
| Gaviscon 500 lemon EACH TABLET CONTAINS CALCIUM CARBONATE 160,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 267,0 mg | 500 | A380445A38/11.10/445 | Registered | Not determined | None |
| Gaviscon peppermint tablets EACH TABLET CONTAINS CALCIUM CARBONATE 80,0 mg SODIUM ALGINATE 250,0 mg SODIUM BICARBONATE 133,5 mg | Tablets | A380446A38/11.10/0446 | Registered | Not determined | None |
| Gaviscon 500 peppermint EACH TABLET CONTAINS CALCIUM CARBONATE 160,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 267,0 mg | 500 | A380447A38/11.10/0447 | Registered | Not determined | None |
| Gaviscon double action liquid EACH 10,0 ml SUSPENSION CONTAINS CALCIUM CARBONATE 325,0 mg SODIUM ALGINATE 500,0 mg SODIUM BICARBONATE 213,0 mg | 10 mlSuspension | A400480A40/11.10/0480Approved 16 August 2024 | Registered | S0 | PIPIL |
Regulatory status
Where S0 sits on the scale
Sold anywhere, no pharmacist needed.
This is the least restricted tier of medicine. You can buy it in an ordinary shop such as a supermarket or petrol station, and no pharmacist needs to be involved in the sale. It may also be advertised to the public, subject to the general advertising rules that apply to all medicines; the label must still carry the schedule mark like every other tier.
Schedule S0, read from the product's PI-PIL leaflet.
Who may supply: Anyone. It may be sold in an ordinary shop, not only in a pharmacy.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.